Alison Oneill is Chief Medical Officer of Surface Oncology, Inc.. Currently has a direct ownership of 0 shares of SURF, which is worth approximately $0. The most recent transaction as insider was on Sep 08, 2023, when has been sold 56,686 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

ALISON ONEILL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 08 2023
SELL
Sale (or disposition) back to the issuer
-
56,686 Reduced 100.0%
0 Common Stock
Aug 01 2023
SELL
Open market or private sale
$6,619 $0.94 p/Share
7,042 Reduced 11.05%
56,686 Common Stock
Aug 03 2022
SELL
Open market or private sale
$7,676 $1.72 p/Share
4,463 Reduced 6.54%
63,728 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
38,000 Added 35.78%
68,191 Common Stock
Jul 21 2021
SELL
Open market or private sale
$90,335 $6.1 p/Share
14,809 Reduced 32.91%
30,191 Common Stock
Mar 01 2020
BUY
Grant, award, or other acquisition
-
45,000 Added 50.0%
45,000 Common Stock
AO

Alison Oneill

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on SURF

Follow Surface Oncology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SURF shares.

Notify only if

Insider Trading

Get notified when an Surface Oncology, Inc. insider buys or sells SURF shares.

Notify only if

News

Receive news related to Surface Oncology, Inc.

Track Activities on SURF